KEROS THERAPEUTICS, INC. (KROS) SEC News March 11, 2026, 17:40 UTC 2 0 comments New Form 3 - Keros Therapeutics, Inc. <b>Filed:</b> 2026-03-11 <b>AccNo:</b> 0001866219-26-000003 <b>Size:</b> 9 KB Comment Full text
PLIANT THERAPEUTICS, INC. (PLRX) SEC News March 11, 2026, 17:30 UTC 2 0 comments New Form 10-K - PLIANT THERAPEUTICS, INC. <b>Filed:</b> 2026-03-11 <b>AccNo:</b> 0001746473-26-000037 <b>Size:</b> 12 MB Comment Full text
TENAYA THERAPEUTICS, INC. (TNYA) SEC News March 11, 2026, 17:30 UTC 2 0 comments New Form 10-K - Tenaya Therapeutics, Inc. <b>Filed:</b> 2026-03-11 <b>AccNo:</b> 0001193125-26-102252 <b>Size:</b> 11 MB Comment Full text
TACTILE SYSTEMS TECHNOLOGY, INC. (TCMD) SEC News March 11, 2026, 17:20 UTC 2 0 comments New Form 3 - TACTILE SYSTEMS TECHNOLOGY INC <b>Filed:</b> 2026-03-11 <b>AccNo:</b> 0001478345-26-000007 <b>Size:</b> 13 KB Comment Full text
PETVIVO HOLDINGS INC. (PETV) SEC News March 11, 2026, 17:19 UTC 2 1 comments LOWENTHAL GARRY N 🟢 acquired 72.0K shares of PetVivo Holdings, Inc. (PETV) at $0.69 Transaction Date: Mar 09, 2026 | Filing ID: 009650 Comment Full text
PETVIVO HOLDINGS INC. (PETV) SEC News March 11, 2026, 17:19 UTC 2 1 comments Director Lai John 🟢 acquired 72.3K shares of PetVivo Holdings, Inc. (PETV) at $0.69 Transaction Date: Mar 09, 2026 | Filing ID: 009649 Comment Full text
CURALEAF HLDGS INC. (CURLF) SEC News March 11, 2026, 17:12 UTC 2 0 comments New Form D - Curaleaf Holdings, Inc. <b>Filed:</b> 2026-03-11 <b>AccNo:</b> 0000912282-26-000425 <b>Size:</b> 13 KB Comment Full text
XWELL, INC. (XWEL) SEC News March 11, 2026, 17:12 UTC 2 0 comments New Form SCHEDULE 13G - XWELL, Inc. <b>Filed:</b> 2026-03-11 <b>AccNo:</b> 0001079973-26-000289 <b>Size:</b> 7 KB Comment Full text
SOLID BIOSCIENCES INC. (SLDB) SEC News March 11, 2026, 17:00 UTC 2 0 comments New Form SCHEDULE 13D/A - Solid Biosciences Inc. <b>Filed:</b> 2026-03-11 <b>AccNo:</b> 0001193125-26-102083 <b>Size:</b> 14 KB Comment Full text
AQUESTIVE THERAPEUTICS, INC. (AQST) SEC News March 11, 2026, 16:52 UTC 2 1 comments Boyd Peter E. 🟡 adjusted position in 92.7K shares (1 derivative) of Aquestive Therapeutics, Inc. (AQST) at $4.29 Transaction Date: Mar 09, 2026 | Filing ID: 003147 Comment Full text